Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan
· Delayed Price · Currency is TWD 39.65
-0.15 (-0.38%)
May 2, 2025, 2:00 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.74 billion as of May 2, 2025. Its market cap has decreased by -19.69% in one year.
Market Cap
1.74B
Enterprise Value
1.16B
Revenue
1.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.65
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 1.74B, an increase of 17.47%. That is a compound annual growth rate of 4.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 1.74B | 17.06% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 174.85B |
| Caliway Biopharmaceuticals | 103.28B |
| Bora Pharmaceuticals Co., LTD. | 73.22B |
| Lotus Pharmaceutical | 57.54B |
| Oneness Biotech | 29.88B |
| Polaris Group | 28.35B |
| Pegavision | 27.14B |
| Lumosa Therapeutics | 26.77B |